ZA856413B - Crystalline sodium salt of d-6-(alpha-((2-oxo-3-furfurylidene-amino-imidazolidin-1-yl)carbonylamino)-2-thienylacetamido)-pencillanic acid,processes for its preparation and its use in medicaments - Google Patents

Crystalline sodium salt of d-6-(alpha-((2-oxo-3-furfurylidene-amino-imidazolidin-1-yl)carbonylamino)-2-thienylacetamido)-pencillanic acid,processes for its preparation and its use in medicaments

Info

Publication number
ZA856413B
ZA856413B ZA856413A ZA856413A ZA856413B ZA 856413 B ZA856413 B ZA 856413B ZA 856413 A ZA856413 A ZA 856413A ZA 856413 A ZA856413 A ZA 856413A ZA 856413 B ZA856413 B ZA 856413B
Authority
ZA
South Africa
Prior art keywords
thienylacetamido
imidazolidin
carbonylamino
oxo
alpha
Prior art date
Application number
ZA856413A
Inventor
Hans-Bodo Koenig
Karl Georg Metzger
Wilfried Schroeck
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of ZA856413B publication Critical patent/ZA856413B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/21—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a nitrogen atom directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D499/44—Compounds with an amino radical acylated by carboxylic acids, attached in position 6
    • C07D499/48—Compounds with an amino radical acylated by carboxylic acids, attached in position 6 with a carbon chain, substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, attached to the carboxamido radical
    • C07D499/58—Compounds with an amino radical acylated by carboxylic acids, attached in position 6 with a carbon chain, substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, attached to the carboxamido radical substituted in alpha-position to the carboxamido radical
    • C07D499/64—Compounds with an amino radical acylated by carboxylic acids, attached in position 6 with a carbon chain, substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, attached to the carboxamido radical substituted in alpha-position to the carboxamido radical by nitrogen atoms
    • C07D499/70—Compounds with an amino radical acylated by carboxylic acids, attached in position 6 with a carbon chain, substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, attached to the carboxamido radical substituted in alpha-position to the carboxamido radical by nitrogen atoms with hetero rings as additional substituents on the carbon chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

1. Sodium salt of D-6-{alpha-[(2-oxo-3- furfurylideneamino-imidazolidin-1-yl)-carbonylamino]-2- thienylacetamido}-penicillanic acid of the formula (I) see diagramm : EP0176716,P8,F2 in pure crystalline form, characterized by the following NMR signals : delta = 9.36 (1H), 9.23 (1H), 7.8 (2H), 7.5 (1H), 7.25 (1H), 7.05 (1H), 6.89 (1H), 6.62 (1H), 6.2 (1H), 5.74 (1H), 5.56 (1H), 4.35 (1H), 3.92 (4H), 1.6 (3H) and 1,5 ppm (3H) (in DMF-d7 ).
ZA856413A 1984-08-25 1985-08-23 Crystalline sodium salt of d-6-(alpha-((2-oxo-3-furfurylidene-amino-imidazolidin-1-yl)carbonylamino)-2-thienylacetamido)-pencillanic acid,processes for its preparation and its use in medicaments ZA856413B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19843431273 DE3431273A1 (en) 1984-08-25 1984-08-25 CRYSTALLINE SODIUM SALT OF THE D-6 - ((ALPHA) - (2-OXO-3-FURFURYL-IDEN-AMINO-IMIDAZOLIDIN-1-YL) -CARBONYLAMINO) -THIENYL-2-ACETAMIDO) -PENICILLANIC ACID, METHODS OF PROCESSING IN MEDICINAL PRODUCTS
CN85106479A CN85106479B (en) 1984-08-25 1985-08-29 Crystalline D-6- { alpha- [ (2-oxo-3-furfurylidene-amino-imidazolidin-1-yl) carbonylamino ] -2-thienylacetamido } -penicillanic acid sodium salt

Publications (1)

Publication Number Publication Date
ZA856413B true ZA856413B (en) 1986-04-30

Family

ID=25741999

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA856413A ZA856413B (en) 1984-08-25 1985-08-23 Crystalline sodium salt of d-6-(alpha-((2-oxo-3-furfurylidene-amino-imidazolidin-1-yl)carbonylamino)-2-thienylacetamido)-pencillanic acid,processes for its preparation and its use in medicaments

Country Status (18)

Country Link
EP (1) EP0176716B1 (en)
JP (1) JPS6157589A (en)
KR (1) KR860001818A (en)
CN (1) CN85106479B (en)
AT (1) ATE34576T1 (en)
AU (1) AU559040B2 (en)
DE (2) DE3431273A1 (en)
DK (1) DK385085A (en)
ES (1) ES8609340A1 (en)
FI (1) FI853211A7 (en)
GR (1) GR852047B (en)
HU (1) HU194893B (en)
IL (1) IL76164A0 (en)
NO (1) NO853188L (en)
NZ (1) NZ213198A (en)
PH (1) PH21842A (en)
PT (1) PT81014B (en)
ZA (1) ZA856413B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW347383B (en) * 1995-10-26 1998-12-11 Biochemie Gmbh A process for the production of a crystalline sodium salt of amoxicillin in ethanol as solvent
US9844374B2 (en) 2014-12-18 2017-12-19 Ethicon Llc Surgical instrument systems comprising an articulatable end effector and means for adjusting the firing stroke of a firing member

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL85039B1 (en) * 1972-02-17 1977-02-26 Tarchomińskie Zakłady Farmaceutyczne Method for the preparation of sodium salt of α-ftminobenzylopeiiicylmy
PL87153B1 (en) * 1973-07-13 1976-12-15 Tarchomińskie Zakłady Farmaceutyczne Method of obtaining crystalline penicillin disodium salt of α-carboxybenzyl
DE2732283A1 (en) * 1977-07-16 1979-01-25 Bayer Ag BETA-LACTAM COMPOUNDS
DE2732323A1 (en) * 1977-07-16 1979-01-25 Bayer Ag BETA-LACTAM COMPOUNDS, THE PROCESS FOR THEIR PRODUCTION AND THEIR USE
JPS5940727A (en) * 1982-07-28 1984-03-06 Fujitsu Ltd Automatic equalization system

Also Published As

Publication number Publication date
ATE34576T1 (en) 1988-06-15
AU559040B2 (en) 1987-02-19
EP0176716A1 (en) 1986-04-09
NZ213198A (en) 1989-02-24
DK385085D0 (en) 1985-08-23
FI853211A0 (en) 1985-08-21
AU4657785A (en) 1986-02-27
KR860001818A (en) 1986-03-22
GR852047B (en) 1985-12-20
FI853211L (en) 1986-02-26
CN85106479B (en) 1988-07-27
EP0176716B1 (en) 1988-05-25
PT81014B (en) 1987-12-30
PH21842A (en) 1988-03-17
HU194893B (en) 1988-03-28
CN85106479A (en) 1987-03-18
ES546379A0 (en) 1986-07-16
ES8609340A1 (en) 1986-07-16
HUT38354A (en) 1986-05-28
PT81014A (en) 1985-09-01
JPS6157589A (en) 1986-03-24
IL76164A0 (en) 1985-12-31
DK385085A (en) 1986-02-26
DE3431273A1 (en) 1986-03-06
NO853188L (en) 1986-02-26
FI853211A7 (en) 1986-02-26
DE3562918D1 (en) 1988-06-30

Similar Documents

Publication Publication Date Title
DE2860643D1 (en) Process for the preparation of aqueous suspensions containing at least 65% by weight of calcium carbonate
EP0228845A3 (en) N-containing heterocyclic compounds, processes for the preparation thereof and composition comprising the same
ES8703438A1 (en) Thia (oxa) diazole derivatives
DE3068029D1 (en) Intermediates for the preparation of thienamycin and process for preparing intermediates
ZA856413B (en) Crystalline sodium salt of d-6-(alpha-((2-oxo-3-furfurylidene-amino-imidazolidin-1-yl)carbonylamino)-2-thienylacetamido)-pencillanic acid,processes for its preparation and its use in medicaments
ES8700650A1 (en) 7-(Aryloxy)-2-naphthoxyalkanecarboxylic acid derivatives, processes for the preparation of these compounds, as well as agents having herbicidal activity containing these compounds.
GB1525351A (en) Benzazepine derivatives and their acid addition salts processes for preparing them and pharmaceutical compositions containing them
EP0306904A3 (en) Phosphoric acid diesters and salts thereof
EP0145618A3 (en) Process for the preparation of n,n'-bis(2-hydroxyethyl) oxamide
IL74269A (en) N-(2-alkoxyaminosulfonyl-benzenesulfonyl)n'-(4,6-dialkylpyrimidin-2-yl)ureas,their production and herbicidal compositions containing them
IL70258A (en) 1,3,4,5-tetrahydrobenzazepine and benzdiazepine derivatives,their preparation and pharmaceutical compositions containing them
FR2400508A1 (en) OXANILIC ACID DERIVATIVES, USEFUL IN PARTICULAR FOR IMPROVING AND CONTROL OF THE SYMPTOMS ASSOCIATED WITH ASTHMA, AND PREPARATION PROCESS
JPS52136165A (en) Purification of pyrrolidine derivatives
DE3461189D1 (en) New 3-alkylthio-2-o-carbamoyl-propane-1.2-diol-1-o-phosphocholines, and processes for their preparation
JPS5279081A (en) Preparation of novel 7-methoxycephalosporins
JPS5414961A (en) Novel 3-hydroxyazetidine-3-carboxylic derivative
JPS5283741A (en) Novel benzoisoxazole derivatives
JPS532479A (en) Synthesis of n-substituted uracils
JPS5278886A (en) Synthesis of 5-fluorouracil derivatives
JPS57126491A (en) Preparation of calcium salt of 3,8-dioxabicyclo-(3,2,1)- octane-1-acetic acid derivative
JPS5634623A (en) Hypotensor
IE44701L (en) Antibacterial 6,7-methylenedioxy quinol0nes